|1.||Lodge, Daniel J: 8 articles (01/2016 - 10/2008)|
|2.||Grace, Anthony A: 8 articles (03/2014 - 08/2006)|
|3.||Perez, Stephanie M: 3 articles (01/2016 - 07/2014)|
|4.||Battaglia, Giorgio: 3 articles (10/2011 - 07/2003)|
|5.||Gill, Kathryn M: 2 articles (03/2014 - 08/2011)|
|6.||Cook, James M: 2 articles (03/2014 - 08/2011)|
|7.||Basso, Ana M: 2 articles (05/2013 - 05/2011)|
|8.||Rueter, Lynne E: 2 articles (05/2013 - 05/2011)|
|9.||Tricklebank, Mark D: 2 articles (03/2012 - 01/2012)|
|10.||Sher, Emanuele: 2 articles (03/2012 - 01/2012)|
|1.||Schizophrenia (Dementia Praecox)
08/01/2006 - "As a test of plausibility for the hypothesis that schizophrenia can result from abnormal brain, especially cerebral cortical, development, these studies examined whether, in the rat, disruption of brain development initiated on embryonic day (E) 17, using the methylating agent methylazoxymethanol acetate (MAM), leads to a schizophrenia-relevant pattern of neural and behavioral pathology. "
01/01/2016 - "One of these involves gestational administration of methylazoxymethanol acetate (MAM) to induce a developmental disruption, which in turn produces a schizophrenia-like phenotype in post-pubertal rats. "
08/03/2015 - "Aberrant high frequency oscillations recorded in the rat nucleus accumbens in the methylazoxymethanol acetate neurodevelopmental model of schizophrenia."
01/01/2015 - "Biochemical and cognitive impairments observed in animal models of schizophrenia induced by prenatal stress paradigm or methylazoxymethanol acetate administration."
03/01/2014 - "Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia."
11/01/1974 - "A model system for studies of colon carcinogenesis: tumor induction by a single injection of methylazoxymethanol acetate."
07/01/1991 - "Medaka were also exposed to a known carcinogen, methylazoxymethanol acetate, to verify that chemicals produced tumors in the test fish. "
03/01/1986 - "Intraocular neoplasms developed in the Japanese medaka, a small fish species, following a single brief exposure to methylazoxymethanol acetate [(MAM-Ac) CAS: 592-62-1]. "
03/01/1986 - "Intraocular neoplasms induced by methylazoxymethanol acetate in Japanese medaka (Oryzias latipes)."
08/01/1985 - "Seven species of small fish were exposed to methylazoxymethanol acetate (MAM-Ac) and tumor development was monitored. "
|3.||Periventricular Nodular Heterotopia
04/01/2015 - "To study the excitability of aberrant nodules, we have examined c-fos activation in organotypic hippocampal slice cultures generated from an animal model of periventricular nodular heterotopia created by treating pregnant rats with methylazoxymethanol acetate. "
09/01/2003 - "The pre-natal administration of methylazoxymethanol acetate (MAM) in rats is able to induce cerebral heterotopia that share striking similarities with those observed in human periventricular nodular heterotopia, a cerebral dysgenesis frequently associated with drug-resistant focal seizures. "
07/01/2003 - "We have previously demonstrated that the antiproliferative agent methylazoxymethanol acetate (MAM) is able to induce in rats cerebral heterotopia that share striking similarities with those observed in human periventricular nodular heterotopia (PNH), a cerebral dysgenesis frequently observed in human patients affected by drug-resistant focal epilepsy. "
12/01/1997 - "No involvement of APC gene mutations in ulcerative colitis-associated rat colon carcinogenesis induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate."
03/01/1999 - "In this study, mutations in the region corresponding to N-terminal phosphorylation sites (codons 1-51) of the rat Ctnnb1 gene were investigated in 20 colon tumors associated with ulcerative colitis and induced with methylazoxymethanol acetate and 1-hydroxyanthraquinone. "
|5.||Body Weight (Weight, Body)
05/01/1977 - "To determine whether changes in the surrounding cells influence the normal development of the cerebellar Purkinje cell dendrites and spine specializations, destruction on the differentiating cell layer was induced in the postnatal mouse by administration of methylazoxymethanol acetate (MAM) (0.05 micronl/gm body weight) at day zero. "
01/01/1976 - "Buffalo strain male and female rats were given methylazoxymethanol acetate (20% solution) intraperitoneally 20 mg/kg body weight weekly for 9 weeks, and killed 27 weeks later. "
01/01/1998 - "F344 rats were given intraperitoneal injections of methylazoxymethanol acetate at a dose level of 25 mg/kg body weight once a week for 8 weeks and were killed 40 weeks after the first injection. "
04/01/1980 - "Eight-week-old male Donryu rats received an intraperitoneal injection of 20 mg/kg body weight of methylazoxymethanol acetate once a week for 6 weeks. "
01/01/1983 - "The effect of methylazoxymethanol acetate on rat liver nuclear and nucleolar RNA synthesis is investigated at various doses (5 to 50 mg/100 g body weight) and for various lengths of time (1 to 24 hr). "
|4.||GABA-A Receptors (GABA(A) Receptor)
|6.||gamma-Aminobutyric Acid (GABA)
|8.||DNA (Deoxyribonucleic Acid)
|9.||1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)
|10.||RNA (Ribonucleic Acid)
|3.||Vagus Nerve Stimulation